9_Medicalization, Markets, and Consumers - Conrad and Leiter

9_Medicalization, Markets, and Consumers - Conrad and...

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
MEDICALIZATION, MARKETS AND CONSUMERS medical service or treatment remains, a private medical market may evolve. Private medical markets emerge when an available medical intervention-frequently medical technology or an "off-label" use of an approved drug- meets consumers willing to pay out of their pockets to receive treatment. Such markets are sustained by consumer demand, and they can be expanded by increasing the availability of the intervention, reducing the cost of the treat- ment, or expanding the range of uses or target populations. Some of these interventions can be seen as medical enhancements rather than treatments for a disease, but this is a slippery slope. This commercialization of medicine has been well-developed in cosmetic surgery (Sullivan 2001), but it exists in other areas as well. The relation of increasing medicalization and private markets for biomedical enhance- ments and technology are illustrated through two cases: the use of human growth hormone for idiopathic shortness and in vitro fertiliza- tion for infertility. Human Growth Hormone and Idiopathic Short Stature Medications are frequently prescribed for "off-label" uses, as treatments of conditions
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 10/10/2010 for the course ENG 000121 taught by Professor Mcgrand during the Spring '10 term at Cornell.

Ask a homework question - tutors are online